Article Type: Generic

Flush from its success in negotiating a new scientific integrity clause in its contract for federal scientists, the Professional Institute of the Public Service of Canada (PIPSC) plans to lend support to the US scientific community in an expected battle with the incoming administration of president Donald Trump.

Toronto is home to the second-largest series ‘A’ venture capital investment in the history of biotechnology with the creation of a $300-million start-up to commercialize induced pluripotent stem cells (iPSC) targeting a range of cardiovascular diseases and neurodegenerative disorders.

Genome Canada’s most recent Large-Scale Applied Research Project (LSARP) competition sheds light on the evolving focus of the agency’s support of Canada’s traditional industries as genomics extend their reach into the sectors underpinning the bioeconomy.

Defence Research and Development Canada (DRDC) is preparing to unveil a DARPA-style approach to meeting the innovation requirements of the armed forces. Set to rollout April 1/17, the as-yet-unnamed initiative aims to tap a far greater share of academic research than it currently does and recognizes that its internal R&D capacity is inadequate to meet the full range of future needs.

Cluster concept well received

The beef industry has developed an updated, multi-disciplinary research strategy to assist the sector in addressing a wide range of high-priority objectives and aligning the mosaic of geographically disbursed research funding agencies.

Talking to innovators: Bombardier’s Fassi Kafyeke

Not since the heady days of Nortel Networks has Canada seen one of its own invest so much in R&D. Excluding Nortel, Canadian aerospace giant Bombardier Inc has spent more than any other company on research and technology development here over the past 15 years — just shy of $12.